Proactiv Blemish Control Body Cream

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the management of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Before initiating treatment, a sensitivity test is recommended for new users. The product should be applied sparingly to one or two small affected areas for the first three days. If no discomfort is experienced, the following dosing instructions may be implemented.

Prior to application, the skin must be thoroughly cleansed. A thin layer of the product should be applied to cover the entire affected area. The product may be rinsed off thoroughly one to three times daily, depending on the individual's response and as directed by a healthcare professional.

To minimize the risk of excessive skin drying, it is advisable to start with one application per day. Based on the patient's tolerance and clinical response, the frequency may be gradually increased to two or three times daily. Should bothersome dryness or peeling occur, the application frequency should be reduced to once daily or every other day.

Contraindications

Use is contraindicated in patients with a history of eye contact, as exposure may lead to irritation. In the event of contact with the eyes, it is essential to rinse thoroughly with water. No other contraindications have been identified.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients that the application of this product may lead to skin irritation and dryness, particularly if used concurrently with other topical acne medications. In cases of irritation, it is recommended that patients limit their use to one topical acne medication at a time to minimize adverse effects.

It is imperative to avoid contact with the eyes. Should contact occur, patients should be instructed to rinse their eyes thoroughly with water to mitigate potential irritation.

This product should be stored out of reach of children to prevent accidental ingestion. In the event of swallowing, immediate medical assistance should be sought, or the patient should contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware that it is for external use only. The most common adverse reactions reported include skin irritation and dryness, particularly when used concurrently with other topical acne medications. To minimize the risk of these reactions, it is advised that patients use only one topical acne medication at a time.

Additionally, care should be taken to avoid contact with the eyes. In the event of accidental contact, patients should rinse their eyes thoroughly with water to alleviate any potential discomfort.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Proactiv Blemish Control Body Cream (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this product. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For new users, a sensitivity test is recommended. The product should be applied sparingly to one or two small affected areas during the first three days. If no discomfort occurs, patients may proceed with the full application as directed.

Due to the potential for excessive skin drying, it is advised to start with one application daily. Depending on the patient's response, the frequency may be gradually increased to two or three times daily, or as directed by a healthcare professional. Should bothersome dryness or peeling develop, the application frequency should be reduced to once a day or every other day.

Geriatric Use

There is no specific information regarding the use of Proactiv Blemish Control Body Cream in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this product to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

The safety of salicylic acid during pregnancy has not been established. Salicylic acid is contraindicated in pregnancy due to potential risks to the fetus, including the risk of teratogenic effects associated with its use. Pregnant women should avoid the use of this product unless directed by a healthcare provider. It is recommended that women who are pregnant or planning to become pregnant consult a healthcare professional before using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or recommendations regarding the use of Proactiv Blemish Control Body Cream in lactating mothers. Additionally, there is no information available about the potential for excretion of this product in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control experts is recommended to guide treatment decisions and ensure optimal patient care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. In the event of swallowing the medication, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be informed that the use of this medication may lead to skin irritation and dryness, particularly if they are using another topical acne medication concurrently. It is recommended that patients use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should instruct patients to avoid contact with the eyes. If contact occurs, patients should rinse their eyes thoroughly with water to alleviate any potential discomfort.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a controlled temperature range of 20-25°C (68-77°F) to maintain its integrity and efficacy. Proper storage conditions should be ensured to prevent any degradation of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Proactiv Blemish Control Body Cream, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)